Page 11 - PR 2014 2016 06 Radiopharmacy
P. 11

Radiopharmacy | Progress Report  133





               resulting in at least 3 finalized doctorates   regulations for GMP and marketing authoriza-
               and other still in progress.                   tion of radiopharmaceuticals were published
                                                              by ANVISA (Resolution RDC 63 and 70). The
               Quality Assurance in                           “Technical Committee of Radiopharmaceuticals”

               Radiopharmaceutical                            from the Brazilian Pharmacopoeia is elaborat-

               production                                     ing the monographies of radiopharmaceuticals
                                                              produced in Brazil. IPEN participates in this
                                                              work group which reflects the importance of
               Preparation of radiopharmaceuticals for in-    the radiopharmaceuticals in the context of
               jection involves adherence to regulations in   pharmaceutical production in Brazil. In the
               radiation protection as well as to appropriate   Radiopharmacy, the Quality Assurance Man-
               rules of working under aseptic conditions that   agement is responsible for maintenance and
               should follow the regulations on current Good   improvement of the Quality Management
               Manufacturing Practices (cGMP). Good Manu-     System (according to ISO-9001-2008) and the
               facturing Practices (GMP) is a system designed   implementation of all the aspects related to
               to ensure that pharmaceuticals are consistent-  GMP in production and quality control of radio-
               ly produced and controlled according to quality   pharmaceuticals. There is a group responsible
               standards, with a view to eliminating the risks   for control, maintenance and improvement of
               involved in drug production. The compliance    data generated in the production and quality
               of GMP is directed to minimize the risks pre-  control process and all documents of the Qual-
               sented in the pharmaceutical production that   ity Management System. The accompaniment
               cannot be detected in the analysis of the final   of non-conformities generated in the System
               product: cross-contamination, contamination    and the attention to the fulfillment of ISO 9001
               with particulate material and change or mix-   are also attributions of this group. The Quality
               ture of products. Quality Assurance is a wide   Assurance Management coordinates the In-
               ranging concept which covers all matters that   strument Calibration, Equipment Qualification,
               individually or collectively influence the qual-  Process Validation and also the implementa-
               ity of a product. It is the total arrangements   tion of other GMP requirements. The Quali-
               to ensure that medicinal products have the     ty Assurance Management can oversee the
               required quality for their intended use. Quality   production and quality control operations to
               assurance therefore incorporates GMP and       ensure that a radiopharmaceutical is produced
               thus Quality Control. Because of their short   according the specifications. It is the respon-
               half-lives, many radiopharmaceuticals are      sible for approving or rejecting components,
               released and administered to patients shortly   in-process materials and finished product to
               after their production, so that quality control   ensure compliance with procedures and spec-
               (e.g. tests for sterility and radionuclidic purity)   ifications affecting the identity, concentration,
               may sometimes be retrospective. The imple-     quality and purity of the radiopharmaceutical.
               mentation and compliance with the quality      In the last years, the maintenance of the ISO
               assurance program are therefore essential.     9001 Quality Management System Certifica-
               Manufacturing practices are the methods, fa-   tion was very important and contributed to
               cilities, and controls used in the preparation,   the introduction of the GMP concepts.
               processing, packaging, or holding of a drug. The
               GMP in Brazil is published in the Resolution   Some aspects of the GMP applied to the Quality
               RDC 17 of 16 April, 2010 of ANVISA. Specific   Assurance Program are of special interest and
   6   7   8   9   10   11   12   13   14   15   16